Heart stent study tracks outcomes in over 2,000 chinese patients
NCT ID NCT03273023
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the PROMUS PREMIER stent works in everyday medical practice in China. Over 2,000 people with coronary artery disease received the stent and were followed for 12 months to track major heart problems like heart attacks or the need for another procedure. The goal was to see if the stent performs safely and effectively outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PROMUS PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System
What this could lead to
If successful, this study could confirm that the PROMUS PREMIER stent works well in real-world Chinese patients, supporting its continued use for treating blocked heart arteries.
What could go wrong
This is a post-approval observational study, not a randomized trial, so results may not prove the stent is better than other options. Risks include heart attack, need for repeat procedures, or stent-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China